| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.48B | +16.4% |
| Cost of Revenue | $665.1M | -43.0% |
| R&D Expense | $226.5M | -64.5% |
| SG&A Expense | $233.5M | +28.9% |
| Operating Income | $4.15B | +121.6% |
| Interest Expense | $207.0M | -35.0% |
| Pre-tax Income | $3.95B | +150.8% |
| Income Tax | $519.7M | — |
| Net Income | $3.33B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.49B | +235.5% |
| Accounts Receivable | $1.82B | +28.6% |
| Current Assets | $4.43B | +91.6% |
| Total Assets | $7.26B | +23.7% |
| Current Liabilities | $1.33B | +26.1% |
| Long-term Debt | $3.51B | +0.1% |
| Total Liabilities | $5.12B | +7.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.97B | +89.2% |
| Investing Cash Flow | $358.4M | +435.8% |
| Financing Cash Flow | -$2.59B | -48.2% |
| +111.0% |
| EPS (Basic) | $9.84 | +110.3% |
| EPS (Diluted) | $9.75 | +115.2% |
| Stockholders' Equity |
| $2.13B |
| +95.9% |